Great sleuthing Chau. Makes you wonder: was he pushed out due to Novartis deal delay or potential fail, or left because he is not getting a deserved position in the new world order post say an acquisition by Novartis. In any case, could be a significant signal/development, hard to pick positive/negative. At the very least it's fair to say he believes in the product given his move to Takeda/Alfosil.
Cell Therapy News/Articles, page-9970
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
95.0¢ |
Change
0.025(2.70%) |
Mkt cap ! $1.084B | |||
| Open | High | Low | Value | Volume |
| 94.0¢ | 96.8¢ | 93.5¢ | $4.207M | 4.417M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 42268 | 94.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 95.0¢ | 48002 | 3 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |